FRACTURE RISK ASSESSMENT Determining your risk of breaking a bone Rather than relying solely on the results of a bone mineral density (BMD) test to make treatment decisions for osteoporosis, […]

As pandemic restrictions begin to lift, you may be thinking about travelling. Today, in addition to considering your plans to travel with osteoporosis you must also be clear on travel […]

GIVE A PLANNED GIFT Many friends of Osteoporosis Canada find peace of mind knowing they have provided for a charitable organization that has enriched their lives or the lives of […]

Osteoporosis Canada (OC) is pleased to announce the updated version of “Key performance indicators (KPIs) for Canadian FLSs (v2.0)”. Version 2 of the OC FLS KPIs brings in new learnings […]

Updates on Bone Health:Physical activity and exercise Updates on Bone Health:Physical activity and exercise A continuing education program for those treating and training people with osteoporosis. Your presenters are: Barb […]

Anti-Racism Statement Anti-Racism Statement Osteoporosis Canada is committed to the removal of anti-Black systemic barriers negatively affecting the lives of Black Canadians. Osteoporosis Canada is committed to anti-racism and anti-oppression, […]

Strontium ranelate (Protelos) is a drug approved for the treatment of osteoporosis in Europe, but not in Canada. It is effective in reducing fractures . Recently the European Medicines Agency […]

Latest News IAB Membership Cycle Applications Being Accepted January 12, 2024 Canadian Institutes of Health Research (CIHR) The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for […]

Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]